StockpollyBeta
Get App
Popularity #737
BDX · NYSE · Medical - Instruments & Supplies

BD (BDX)

Medical devices and connected systems spanning everyday care, drug delivery, monitoring, and intervention.

$182.57
vs last close−0.43 (−0.23%)

In millions of USD, except per-share figures

In millionsQ4 FY23Sep 2023Q1 FY24Dec 2023Q2 FY24Mar 2024Q3 FY24Jun 2024Q4 FY24Sep 2024Q1 FY25Dec 2024Q2 FY25Mar 2025Q3 FY25Jun 2025Q4 FY25Sep 2025Q1 FY26Dec 2025Q2 FY26Mar 2026Q3 FY26Jun 2026
Revenue5,0874,7065,0454,9905,4375,1685,2725,5095,8905,2524,7144,983
Cost of revenue3,3862,6792,7412,6832,9502,9333,0152,8753,0922,9082,5602,668
Gross profit1,7012,0272,3042,3072,4872,2352,2572,6342,7982,3442,1542,315
1,3521,5881,5701,7051,8651,7821,7111,7522,1021,7502,0611,652
Research & development281290299299302343302297322318249258
1,1381,2131,1931,1961,2561,3181,2731,3201,3661,4321,2131,261
General & administrative0000000001,4321,2131,261
Other expenses−6785782103071211361354140599133
Operating income34943973460262245354688269759494663
−168−80−101−102−108−147−183−179−187−107−55−109
Interest income93426485523555494
Interest expense113111125137155155151152155107149132
Other non-operating income55−31−24−35−47−83227320−95−23
Income before tax18135963350051430636370351048739554
Income tax expense277796131143551291710576103
Net income from continuing operations154282537487400303308574493382−37451
Discontinued operations−46000000000−274−74
Net income108281537487400303308574493382−311377
EPS, basic$0.37$0.97$1.85$1.68$1.45$1.05$1.07$2.00$1.72$1.34−$1.11$1.37
EPS, diluted$0.37$0.96$1.85$1.68$1.45$1.04$1.07$2.00$1.72$1.34−$1.11$1.37
Weighted average shares, basic291290290290290290288288287285281275
Weighted average shares, diluted293291290290291290289289287285281275
EBITDA8811,0311,3291,2051,2551,0681,1221,4731,2941,208709686
Depreciation & amortization5875615715685866076086186296145200
EBIT294470758637669461514855665594189686